‌

US Patent 10039817 Immunomodulatory minicells and methods of use

Patent 10039817 was granted and assigned to Vaxiion Therapeutics on August, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Vaxiion Therapeutics

Current Assignee

Vaxiion Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

100398170

Patent Inventor Names

Matthew J. Giacalone0

Date of Patent

August 7, 2018

Patent Application Number

154251810

Date Filed

February 6, 2017

Patent Citations Received

‌

US Patent 11970518 Compositions and methods for the encapsulation and scalable delivery of agrochemicals

‌

US Patent 11624061 Compositions and methods for enzyme immobilization

‌

US Patent 11649265 Compositions and methods for the encapsulation and scalable delivery of agrochemicals

Patent Primary Examiner

‌

Rodney P Swartz

Patent abstract

The present disclosure is related to immunomodulatory bacterial minicells and methods of using the minicells.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10039817 Immunomodulatory minicells and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API